Article Details

Arteaus Therapeutics sells royalty interest in Emgality for $260 mln

Retrieved on: 2019-04-01 01:37:30

Tags for this article:

Click the tags to see associated articles and topics

Arteaus Therapeutics sells royalty interest in Emgality for $260 mln. View article details on hiswai:

Excerpt

<div>Arteaus Therapeutics, a biotech development company co-founded by <b>Atlas</b> <b>Venture</b> and OrbiMed, has sold its royalty interest in Eli Lilly and ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up